by Bernard Siegel | Apr 12, 2017 | News & Opinions, Policy
Columnist Mitchell Hiltzik savaged the La Jolla-based StemGenix Medical Center “The stem cell therapies offered by La Jolla clinic aren’t FDA approved, may not work- and cost $15,000” reads the title of his piece on the LA Times. StemGenix is the subject of a federal...
by Bernard Siegel | Apr 10, 2017 | Bioethics, News & Opinions, Policy
Sheef /ʃiːf/ noun acronym. Synthetic Human Entity with Embryo-like Features. “Change is avalanching upon our heads and most people are grotesquely unprepared to cope with it.” Alvin Toffler (1970)- Future Shock Stem cell engineering has leaped forward so fast that...
by Joseph Dawson | Apr 6, 2017 | News & Opinions
Left to right are Bernard Siegel, J.D., keynote speaker, and Andre Terzic, M.D., Ph.D., medical director, Center for Regenerative Medicine, at the Mayo Clinic Symposium on Regenerative Medicine and Surgery.March 31, 2017 As a large medical practice, Mayo Clinic...
by Bernard Siegel | Apr 4, 2017 | News & Opinions, Science
A Japanese man has been the first human to receive “reprogrammed” stem cells from another person. As I discussed in detail in a recent post, Japan has implemented a national strategy to develop and translate induced pluripotent stem cells technologies. Japanese...
by Bernard Siegel | Mar 31, 2017 | News & Opinions, Science
What are the implications of scientists creating “immortal” cell lines comprised of healthy red blood cells for transplant and research? An article written by CNN producer Michael Nedelman reports that British scientists, led by University of Bristol researcher Jan...
by Bernard Siegel | Mar 16, 2017 | News & Opinions, Science
The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine,has announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord. The...
